{
    "2018-09-15": [
        [
            {
                "time": "",
                "original_text": "市场渐成红海 华东医药拟15亿元收购亏损公司加码医美",
                "features": {
                    "keywords": [
                        "华东医药",
                        "收购",
                        "亏损公司",
                        "医美"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华东医药14.9亿元收购英医美公司Sinclair",
                "features": {
                    "keywords": [
                        "华东医药",
                        "收购",
                        "Sinclair",
                        "医美"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "医美"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "全球股市普涨 A 股为何白马也失蹄？",
                "features": {
                    "keywords": [
                        "全球股市",
                        "普涨",
                        "A股",
                        "白马股"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "多家药企回应\"带量采购\" 未来仿制药价格或走低",
                "features": {
                    "keywords": [
                        "药企",
                        "带量采购",
                        "仿制药",
                        "价格走低"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}